A new generation of clinical endpoint trials in HIV

被引：0
|
作者：
Neaton, JD [1 ]
Babiker, AGA [1 ]
机构：
[1] Univ Minnesota, Minneapolis, MN 55455 USA
来源：
CONTROLLED CLINICAL TRIALS | 2003年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
16
引用
收藏
页码：51S / 51S
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant Rectal (NAR) Score: a New Surrogate Endpoint in Rectal Cancer Clinical Trials
    George, Thomas J., Jr.
    Allegra, Carmen J.
    Yothers, Greg
    CURRENT COLORECTAL CANCER REPORTS, 2015, 11 (05) : 275 - 280
  • [22] Evaluation of the True Endpoint of Clinical Trials for Cancer Cachexia
    Naito, Tateaki
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2019, 6 (03) : 227 - +
  • [23] Sizing clinical trials with variable endpoint event rates
    Moye, LA
    STATISTICS IN MEDICINE, 1997, 16 (20) : 2267 - 2282
  • [24] Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation
    Hilbrands, Luuk
    Budde, Klemens
    Bellini, Maria Irene
    Diekmann, Fritz
    Furian, Lucrezia
    Grinyo, Josep
    Heemann, Uwe
    Hesselink, Dennis A.
    Loupy, Alexandre
    Oberbauer, Rainer
    Pengel, Liset
    Reinders, Marlies
    Schneeberger, Stefan
    Naesens, Maarten
    TRANSPLANT INTERNATIONAL, 2022, 35
  • [25] New-generation NNRTIs: update of clinical trials
    Caby, F.
    Katlama, C.
    VIROLOGIE, 2008, 12 : S45 - S52
  • [26] A potential primary endpoint for clinical trials in glaucoma neuroprotection
    De Moraes, Carlos Gustavo
    Lane, Keith J. J.
    Wang, Xiao
    Liebmann, Jeffrey M. M.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [27] 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
    Hicks, Karen A.
    Mahaffey, Kenneth W.
    Mehran, Roxana
    Nissen, Steven E.
    Wiviott, Stephen D.
    Dunn, Billy
    Solomon, Scott D.
    Mar-Ler, John R.
    Teerlink, John R.
    Farb, Andrew
    Morrow, David A.
    Targum, Shari L.
    Sila, Cathy A.
    Hai, Mary T. Thanh
    Jaff, Michael R.
    Joffe, Hylton V.
    Cutlip, Donald E.
    Desai, Akshay S.
    Lewis, Eldrin F.
    Gibson, C. Michael
    Landray, Martin J.
    Lincoff, A. Michael
    White, Christopher J.
    Brooks, Steven S.
    Rosenfield, Kenneth
    Domanski, Michael J.
    Lansky, Alexandra J.
    McMurray, John J. V.
    Tcheng, James E.
    Steinhubl, Steven R.
    Burton, Paul
    Mauri, Laura
    O'Connor, Christopher M.
    Pfeffer, Marc A.
    Hung, H. M. James
    Stockbridge, Norman L.
    Chaitman, Bernard R.
    Temple, Robert J.
    CIRCULATION, 2018, 137 (09) : 961 - 972
  • [28] A potential primary endpoint for clinical trials in glaucoma neuroprotection
    Carlos Gustavo De Moraes
    Keith J. Lane
    Xiao Wang
    Jeffrey M. Liebmann
    Scientific Reports, 13
  • [29] Endpoint Definitions in Clinical Trials Consensuses, A Synonym for Dissensuses?
    Toth, Gabor G.
    Wijns, William
    JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (09) : 885 - 889
  • [30] Endpoint Selection in Randomized Clinical Trials for Hypertrophic Cardiomyopathy
    Aimo, Alberto
    Olivotto, Iacopo
    Todiere, Giancarlo
    Barison, Andrea
    Panichella, Giorgia
    Fiuzat, Mona
    Linde, Cecilia
    Lakdawala, Neal K.
    Desai, Milind
    Zannad, Faiez
    Maron, Martin S.
    JACC-HEART FAILURE, 2025, 13 (02) : 200 - 212
12345